<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Pillar Clinical Research News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Pillar Clinical Research.</description>
		<lastBuildDate>Mon, 13 Jul 2026 05:30:25 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Pillar Clinical Research News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/450263.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/785788</guid>
			<title>Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision</title>
			<pubDate>Fri, 24 May 2019 10:00:00 -0400</pubDate>
			<description>The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site rating consultation for difficult cases. The goal of Pillar Precision is to minimize the placebo response, select appropriate [PR.com]</description>
			<link>https://www.pr.com/press-release/785788</link>
			<dc:creator>Pillar Clinical Research</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/783010</guid>
			<title>Texas Clinical Research Company Announces Expansion and New Quality Assurance Initiative</title>
			<pubDate>Thu, 18 Apr 2019 15:00:00 -0400</pubDate>
			<description>Pillar Clinical Research (Pillar), with a focus on early and late stage CNS drug development, opens two new US research facilities in Illinois and Arkansas and adds Director of Quality Assurance.  Dr. Andrew Kim joined the Chicago team in September of 2018, and has spent over 5 years in clinical research and 10 years in clinical practice. He stated, &#8220;I am very excited to be part of the Pillar Clinical Research team [PR.com]</description>
			<link>https://www.pr.com/press-release/783010</link>
			<dc:creator>Pillar Clinical Research</dc:creator>
		</item>
	</channel>
</rss>